New delhi, Nov 09: Revised maximum retail prices of 1,364 anti-cancer medicine formulations covering 121 drugs have come into effect from Monday, with consumers expected to save an estimated ₹3,540.38 crore annually.
The National Pharmaceutical Pricing Authority, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the MRPs of 137 anti-cancer drugs following recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026.
According to the Ministry, as of November 8, a total of 85 pharmaceutical companies had reported revised MRPs for 1,364 formulations. Of these, 679 brands have reported price reductions of more than 50%, while the highest reported reduction stands at 96.45%.
The revised prices are aimed at making cancer treatment more affordable and reducing the financial burden on patients and their families.
Consumers can check the revised MRP printed on medicine packs and verify prices through the Pharma Sahi Daam mobile application or the NPPA website at nppa.gov.in.
The NPPA has clarified that no chemist or hospital pharmacy can charge more than the revised MRP. Consumers can register complaints regarding overcharging or other pricing-related grievances through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.
|